Weight loss might help reverse progression of a common heart arrhythmia in obese adults, a new study shows. Researchers found that when obese adults with atrial fibrillation (a-fib) shed at least 10 percent of […]
Achaogen, Inc., a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multidrug resistant (MDR) gram-negative infections, today announced that the U.S. Food and Drug Administration (FDA) has approved Zemdri (plazomicin) for adults with […]
Starpharma and Mundipharma have signed a licence agreement for the sales and marketing rights to VivaGel BV for 43 countries in Europe, Russia, the Commonwealth of Independent States (CIS) and the balance of countries in […]
Pfizer said that its breast cancer drug Ibrance (palbociclib) in combination with fulvestrant was not statistical significant in extending overall survival (OS) in a phase 3 Paloma-3 trial. The study assessed Ibrance in combination […]
The Dementia Discovery Fund (DDF) has announced the completion of its fundraising, with £250m ($350m at the time of completion) raised from an influential group of strategic investors committed to developing new medicines for dementia. […]